Charles River Laboratories (CRL)

Operating return on assets (Operating ROA)

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Operating income (ttm)	US$ in thousands	227,347	527,956	562,053	575,346	617,261	648,149	647,623	670,089	650,975	659,972	664,798	614,937	589,862	545,982	522,933	462,151	432,729	412,591	372,640	375,640
Total assets	US$ in thousands	7,528,340	8,003,840	7,948,280	8,152,780	8,195,000	7,607,010	7,772,380	7,699,440	7,602,770	7,382,770	7,529,360	7,075,050	7,024,290	7,058,440	6,720,350	5,808,960	5,490,830	5,213,340	5,240,880	5,201,790
Operating ROA		3.02%	6.60%	7.07%	7.06%	7.53%	8.52%	8.33%	8.70%	8.56%	8.94%	8.83%	8.69%	8.40%	7.74%	7.78%	7.96%	7.88%	7.91%	7.11%	7.22%

December 31, 2024 calculation

Operating ROA = Operating income (ttm) ÷ Total assets
= $227,347K ÷ $7,528,340K
= 3.02%

Charles River Laboratories' operating return on assets (Operating ROA) has shown some fluctuations over the analyzed period. The ratio saw a moderate increase from March 2020 to March 2022, reaching a high of 8.83% in June 2022. However, the ratio decreased to 7.06% by June 2024, showing a downward trend.

Overall, the average Operating ROA for Charles River Laboratories over the period analyzed is approximately 7.88%. This indicates that, on average, the company generates a return of 7.88% on its assets through its operations.

It is important for the company to closely monitor and manage its operating efficiency and asset utilization to maintain or improve its Operating ROA in order to maximize profitability and shareholder value in the long term.